What is the first-line treatment for delirium?

First-Line Treatment for Delirium

The first-line treatment for delirium is a multicomponent, nonpharmacologic intervention focused on reducing modifiable risk factors, improving cognition, optimizing sleep, mobility, hearing, and vision—NOT antipsychotic medications 1.

Nonpharmacologic Interventions (Primary Treatment)

The 2018 Critical Care Medicine guidelines provide a conditional recommendation for multicomponent nonpharmacologic strategies as the foundation of delirium management 1. These interventions should include:

• Reorientation and cognitive stimulation (use of clocks, calendars, familiar objects)
• Sleep optimization (minimize light and noise, cluster care activities)
• Reduced sedation to improve wakefulness
• Early mobilization and rehabilitation
• Sensory optimization (ensure hearing aids and eyeglasses are available and used)

This approach has demonstrated significant reductions in delirium incidence, ICU delirium duration, ICU length of stay, and hospital mortality 1. The ABCDEF bundle (Assessment of pain, Both spontaneous awakening and breathing trials, Choice of sedation, Delirium monitoring, Early mobility, Family engagement) showed reduced mortality and more ICU days without coma or delirium when bundle compliance improved 1.

Pharmacologic Treatment (Reserved, Not Routine)

Antipsychotics should NOT be used routinely to treat delirium 1. The guideline explicitly recommends against routine use of haloperidol, atypical antipsychotics, or statins, as RCTs showed no association with shorter delirium duration, mechanical ventilation time, ICU length of stay, or decreased mortality 1.

When Pharmacologic Treatment May Be Warranted

Despite lack of evidence, short-term use of haloperidol or atypical antipsychotics may be considered ONLY for 1:

• Significant distress from hallucinations or delusion-associated fearfulness
• Agitation that poses physical harm to the patient or others

All antipsychotics must be discontinued immediately once distressful symptoms resolve 1.

Dexmedetomidine Exception

For mechanically ventilated adults where agitation is precluding weaning/extubation, dexmedetomidine is suggested as a treatment option 1. This is a specific clinical scenario, not general delirium treatment.

Clinical Algorithm

1. Identify and treat underlying causes (infections, metabolic derangements, medications, hypoxia)
2. Implement multicomponent nonpharmacologic interventions immediately
3. Avoid routine antipsychotic use
4. Consider short-term antipsychotics ONLY if:
   • Patient has severe distress from psychotic symptoms, OR
   • Agitation poses imminent physical danger
5. Use dexmedetomidine if agitation prevents ventilator liberation
6. Discontinue antipsychotics as soon as symptoms resolve

Important Caveats

The Swiss Smarter Medicine campaign reinforces this approach, emphasizing that haloperidol should not be reflexively prescribed and that nonpharmacologic interventions with treatment of underlying causes should be prioritized 2. When antipsychotics are necessary, prescribe cautiously considering contraindications (QTc prolongation risk) and potential side effects 2.

Exception: Benzodiazepines (not antipsychotics) are first-line for alcohol withdrawal delirium specifically 3, 4.

The evidence consistently shows that while older literature suggested haloperidol as first-line 5, 4, the highest quality guideline evidence from 2018 definitively contradicts this practice for routine use 1.